Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (1,656,397)	$ (7,754,524)	$ (375,189)		$ (9,782,075)
Non-controlling interest
Adjustments to reconcile net loss to cash flows from operating activities:
Iniatial valuation of debt discount					239,300
Loss on settlement	5,000	232,776	80,000		382,635
Gain on loss of control of VIE			(313,928)
Return on EB5 Investment			500,000
Amortization of debt discount			1,845,925		330,192
Stock based compensation	47,250	6,029,550	66,000		6,041,550
Change in fair value of derivative liability			(3,992,108)		273,299
Change in exercise of warrant			(70,389)		67,387
Depreciation			44,684	$ 110,032	46,189
Amortization of intangible assets			700		700
Change in financing cost			316,261
Changes in assets and liabilities:
Accounts receivable			122,971		60,145
Inventory			(83,253)		(138,801)
Prepayment, deposits and other receivables			(855,878)		261,183
Other assets					(35,000)
Other payables			404,993		37,962
Accounts payable and accrued liabilities			465,435		5,955
Customer deposits			137,313		(62,174)
Unearned revenue			3,909		(19,890)
Right of use assets			119,483		39,169
Lease liability			(118,078)		(36,919)
Investment to Indigo Dye			(564,818)
Interest Payable			98,780		166,753
Net cash used in operating activities			(2,167,187)		(2,122,441)
Cash flows from investing activities:
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from shares issuance					340,000
Bank overdraft					5,907
Loan receivable			(13,911)		75,033
Loan receivable - related parties			38,044
Proceeds from advanced shares issuance					236,000
Proceeds (Repayment) from(to) loans payable - related parties			540,281		105,000
Proceeds from convertible notes			1,804,900		1,451,687
Repayment of convertible notes			(227,700)
Reduction of cash due to Indigo Dye deconsolidation			(326,811)
Proceeds (Repayment) from(to) loans			271,929		(22,555)
Net cash provided by financing activities			2,086,732		2,191,072
Net increase (decrease) in cash			(80,455)		68,631
Cash paid during the period for:
Cash, beginning of period			441,004	103,002	34,371
Cash, end of period	$ 360,550	$ 103,002	360,550	$ 441,004	103,002
Supplemental disclosure of non-cash financing activities -
Shares issued for conversion of convertible debt			1,594,338		689,997
Reduction in derivative liability due to conversion			2,336,779		957,488
Debt discount related to convertible debt			2,010,717		951,581
Debts settled through shares issuance					229,000
Shares issued for award to Bizright and to be cancelled in future					(32,291,060)
Shares issued for warrant exercise					$ 28,381